Fluticasone	NN	B-NP	O	Other	No	No	Other	Other	###	1	Fluticasone	Fluticasone	NN	NN	_	2	compound	_	_
propionate	NN	I-NP	O	Other	No	No	Other	Other	###	2	propionate	propionate	NN	NN	_	3	nsubj	_	_
impairs	VBZ	B-VP	O	Other	No	No	Other	B-Negative_regulation	###	3	impairs	impairs	VBZ	VBZ	_	0	root	_	_
GATA-3	NN	B-NP	B-protein	B-Protein	No	No	B-Protein	Other	###	4	GATA-3	GATA-3	NN	NN	_	5	compound	_	_
interaction	NN	I-NP	O	Other	No	No	Other	B-Binding	###	5	interaction	interaction	NN	NN	_	3	dobj	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	6	with	with	IN	IN	_	7	case	_	_
importin-alpha	NN	B-NP	B-protein	Other	No	No	Other	Other	###	7	importin-alpha	importin-alpha	NN	NN	_	5	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	8	and	and	CC	CC	_	7	cc	_	_
GATA-3	NN	I-NP	B-protein	B-Protein	No	No	B-Protein	Other	###	9	GATA-3	GATA-3	NN	NN	_	11	compound	_	_
nuclear	JJ	I-NP	O	Other	No	No	Other	Other	###	10	nuclear	nuclear	JJ	JJ	_	11	amod	_	_
localization	NN	I-NP	O	Other	No	No	Other	B-Localization	###	11	localization	localization	NN	NN	_	7	conj	_	_
in	FW	B-ADVP	O	Other	No	No	Other	Other	###	12	in	in	FW	FW	_	13	compound	_	_
vivo	FW	I-ADVP	O	Other	No	No	Other	Other	###	13	vivo	vivo	FW	FW	_	14	advmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	14	and	and	CC	CC	_	3	advmod	_	_
ex	FW	B-ADVP	O	Other	No	No	Other	Other	###	15	ex	ex	FW	FW	_	16	compound	_	_
vivo	FW	I-ADVP	O	Other	No	No	Other	Other	###	16	vivo	vivo	FW	FW	_	14	advmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	17	.	.	.	.	_	3	punct	_	_

(	(	O	O	Other	No	No	Other	Other	###	1	(	(	(	(	_	2	punct	_	_
A	NN	B-NP	O	Other	No	No	Other	Other	###	2	A	A	NN	NN	_	7	compound	_	_
and	CC	O	O	Other	No	No	Other	Other	###	3	and	and	CC	CC	_	2	cc	_	_
B	NN	B-NP	O	Other	No	No	Other	Other	###	4	B	B	NN	NN	_	2	conj	_	_
)	)	O	O	Other	No	No	Other	Other	###	5	)	)	)	)	_	2	punct	_	_
Co-immunoprecipitation	NN	B-NP	O	Other	No	No	Other	Other	###	6	Co-immunoprecipitation	Co-immunoprecipitation	NN	NN	_	7	compound	_	_
analysis	NN	I-NP	O	Other	No	No	Other	Other	###	7	analysis	analysis	NN	NN	_	19	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	8	of	of	IN	IN	_	9	case	_	_
PBMCs	NNS	B-NP	B-cell_type	Other	No	No	Other	Other	###	9	PBMCs	PBMCs	NNS	NNS	_	7	nmod	_	_
from	IN	B-PP	O	Other	No	No	Other	Other	###	10	from	from	IN	IN	_	13	case	_	_
steroid-naive	JJ	B-NP	O	Other	No	No	Other	Other	###	11	steroid-naive	steroid-naive	JJ	JJ	_	13	amod	_	_
asthma	NN	I-NP	O	Other	No	No	Other	Other	###	12	asthma	asthma	NN	NN	_	13	compound	_	_
patients	NNS	I-NP	O	Other	No	No	Other	Other	###	13	patients	patients	NNS	NNS	_	9	nmod	_	_
treated	VBN	B-VP	O	Other	No	No	Other	Other	###	14	treated	treated	VBN	VBN	_	13	acl	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	15	with	with	IN	IN	_	16	case	_	_
FP	NN	B-NP	O	Other	No	No	Other	Other	###	16	FP	FP	NN	NN	_	14	nmod	_	_
in	FW	B-ADVP	O	Other	No	No	Other	Other	###	17	in	in	FW	FW	_	18	compound	_	_
vitro	FW	I-ADVP	O	Other	No	No	Other	Other	###	18	vitro	vitro	FW	FW	_	14	advmod	_	_
demonstrated	VBD	B-VP	O	Other	No	No	Other	Other	###	19	demonstrated	demonstrated	VBD	VBD	_	0	root	_	_
impaired	JJ	B-NP	O	Other	No	No	Other	B-Negative_regulation	###	20	impaired	impaired	JJ	JJ	_	21	amod	_	_
interaction	NN	I-NP	O	Other	No	Yes	Other	B-Binding	###	21	interaction	interaction	NN	NN	_	19	dobj	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	22	between	between	IN	IN	_	23	case	_	_
GATA-3	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	23	GATA-3	GATA-3	NN	NN	_	21	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	24	and	and	CC	CC	_	23	cc	_	_
importin-alpha	NN	I-NP	B-protein	Other	No	No	Other	Other	###	25	importin-alpha	importin-alpha	NN	NN	_	23	conj	_	_
measured	VBN	B-VP	O	Other	No	No	Other	Other	###	26	measured	measured	VBN	VBN	_	23	acl	_	_
at	IN	B-PP	O	Other	No	No	Other	Other	###	27	at	at	IN	IN	_	29	case	_	_
60	CD	B-NP	O	Other	No	No	Other	Other	###	28	60	60	CD	CD	_	29	nummod	_	_
min	NN	I-NP	O	Other	No	No	Other	Other	###	29	min	min	NN	NN	_	26	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	30	.	.	.	.	_	19	punct	_	_

Each	DT	B-NP	O	Other	No	No	Other	Other	###	1	Each	Each	DT	DT	_	2	det	_	_
bar	NN	I-NP	O	Other	No	No	Other	Other	###	2	bar	bar	NN	NN	_	3	nsubj	_	_
represents	VBZ	B-VP	O	Other	No	No	Other	Other	###	3	represents	represents	VBZ	VBZ	_	0	root	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	4	the	the	DT	DT	_	5	det	_	_
mean+	NN	I-NP	O	Other	No	No	Other	Other	###	5	mean+	mean+	NN	NN	_	3	dobj	_	_
/	/	O	O	Other	No	No	Other	Other	###	6	/	/	/	/	_	5	punct	_	_
-	-	O	O	Other	No	No	Other	Other	###	7	-	-	-	-	_	5	punct	_	_
SEM	NN	I-NP	O	Other	No	No	Other	Other	###	8	SEM	SEM	NN	NN	_	5	dep	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	9	of	of	IN	IN	_	14	case	_	_
at	IN	B-NP	O	Other	No	No	Other	Other	###	10	at	at	IN	IN	_	11	case	_	_
least	JJS	I-NP	O	Other	No	No	Other	Other	###	11	least	least	JJS	JJS	_	12	nmod:npmod	_	_
three	CD	I-NP	O	Other	No	No	Other	Other	###	12	three	three	CD	CD	_	14	nummod	_	_
independent	JJ	I-NP	O	Other	No	No	Other	Other	###	13	independent	independent	JJ	JJ	_	14	amod	_	_
experiments	NNS	I-NP	O	Other	No	No	Other	Other	###	14	experiments	experiments	NNS	NNS	_	5	nmod	_	_
;	:	O	O	Other	No	No	Other	Other	###	15	;	;	:	:	_	3	punct	_	_
***	SYM	B-NP	O	Other	No	No	Other	Other	###	16	***	***	SYM	SYM	_	18	nsubj	_	_
p	NN	I-NP	O	Other	No	No	Other	Other	###	17	p	p	NN	NN	_	18	nsubj	_	_
<	SYM	O	O	Other	No	No	Other	Other	###	18	<	<	SYM	SYM	_	3	parataxis	_	_
0.001	CD	B-NP	O	Other	No	No	Other	Other	###	19	0.001	0.001	CD	CD	_	18	nummod	_	_
compared	VBN	B-PP	O	Other	No	No	Other	Other	###	20	compared	compared	VBN	VBN	_	22	case	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	21	with	with	IN	IN	_	22	case	_	_
control	NN	B-NP	O	Other	No	No	Other	Other	###	22	control	control	NN	NN	_	3	advcl	_	_
as	IN	B-SBAR	O	Other	No	No	Other	Other	###	23	as	as	IN	IN	_	24	mark	_	_
determined	VBN	B-VP	O	Other	No	No	Other	Other	###	24	determined	determined	VBN	VBN	_	22	dep	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	25	by	by	IN	IN	_	29	case	_	_
ANOVA	JJ	B-NP	O	Other	No	No	Other	Other	###	26	ANOVA	ANOVA	JJ	JJ	_	29	amod	_	_
/	/	O	O	Other	No	No	Other	Other	###	27	/	/	/	/	_	29	punct	_	_
Newman-Keuls	JJ	B-NP	O	Other	No	No	Other	Other	###	28	Newman-Keuls	Newman-Keuls	JJ	JJ	_	26	dep	_	_
analysis	NN	I-NP	O	Other	No	No	Other	Other	###	29	analysis	analysis	NN	NN	_	24	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	30	.	.	.	.	_	3	punct	_	_

(	(	O	O	Other	No	No	Other	Other	###	1	(	(	(	(	_	2	punct	_	_
C	NN	B-NP	O	Other	No	No	Other	Other	###	2	C	C	NN	NN	_	7	compound	_	_
and	CC	O	O	Other	No	No	Other	Other	###	3	and	and	CC	CC	_	2	cc	_	_
D	NN	B-NP	O	Other	No	No	Other	Other	###	4	D	D	NN	NN	_	2	conj	_	_
)	)	O	O	Other	No	No	Other	Other	###	5	)	)	)	)	_	2	punct	_	_
Co-immunoprecipitation	NN	B-NP	O	Other	No	No	Other	Other	###	6	Co-immunoprecipitation	Co-immunoprecipitation	NN	NN	_	7	compound	_	_
analyses	NNS	I-NP	O	Other	No	No	Other	Other	###	7	analyses	analyses	NNS	NNS	_	27	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	8	of	of	IN	IN	_	9	case	_	_
PBMCs	NNS	B-NP	B-cell_type	Other	No	No	Other	Other	###	9	PBMCs	PBMCs	NNS	NNS	_	7	nmod	_	_
from	IN	B-PP	O	Other	No	No	Other	Other	###	10	from	from	IN	IN	_	13	case	_	_
steroid-naive	JJ	B-NP	O	Other	No	No	Other	Other	###	11	steroid-naive	steroid-naive	JJ	JJ	_	13	amod	_	_
asthma	NN	I-NP	O	Other	No	No	Other	Other	###	12	asthma	asthma	NN	NN	_	13	compound	_	_
patients	NNS	I-NP	O	Other	No	No	Other	Other	###	13	patients	patients	NNS	NNS	_	9	nmod	_	_
treated	VBN	B-VP	O	Other	No	No	Other	Other	###	14	treated	treated	VBN	VBN	_	13	acl	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	15	with	with	IN	IN	_	17	case	_	_
inhaled	VBN	B-NP	O	Other	No	No	Other	Other	###	16	inhaled	inhaled	VBN	VBN	_	17	amod	_	_
FP	NN	I-NP	O	Other	No	No	Other	Other	###	17	FP	FP	NN	NN	_	14	nmod	_	_
(	(	O	O	Other	No	No	Other	Other	###	18	(	(	(	(	_	20	punct	_	_
500	CD	B-NP	O	Other	No	No	Other	Other	###	19	500	500	CD	CD	_	20	nummod	_	_
microg	NN	I-NP	O	Other	No	No	Other	Other	###	20	microg	microg	NN	NN	_	17	dep	_	_
via	IN	B-PP	O	Other	No	No	Other	Other	###	21	via	via	IN	IN	_	23	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	22	a	a	DT	DT	_	23	det	_	_
spacer	NN	I-NP	O	Other	No	No	Other	Other	###	23	spacer	spacer	NN	NN	_	20	nmod	_	_
)	)	O	O	Other	No	No	Other	Other	###	24	)	)	)	)	_	20	punct	_	_
in	FW	B-ADVP	O	Other	No	No	Other	Other	###	25	in	in	FW	FW	_	26	compound	_	_
vivo	FW	I-ADVP	O	Other	No	No	Other	Other	###	26	vivo	vivo	FW	FW	_	14	advmod	_	_
demonstrated	VBD	B-VP	O	Other	No	No	Other	Other	###	27	demonstrated	demonstrated	VBD	VBD	_	0	root	_	_
decreased	VBN	B-NP	O	Other	No	No	Other	B-Negative_regulation	###	28	decreased	decreased	VBN	VBN	_	29	amod	_	_
association	NN	I-NP	O	Other	No	No	Other	B-Binding	###	29	association	association	NN	NN	_	27	dobj	_	_
between	IN	B-PP	O	Other	No	No	Other	Other	###	30	between	between	IN	IN	_	31	case	_	_
GATA-3	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	31	GATA-3	GATA-3	NN	NN	_	29	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	32	and	and	CC	CC	_	31	cc	_	_
importin-alpha	NN	I-NP	B-protein	Other	No	No	Other	Other	###	33	importin-alpha	importin-alpha	NN	NN	_	31	conj	_	_
.	.	O	O	Other	No	No	Other	Other	###	34	.	.	.	.	_	27	punct	_	_

The	DT	B-NP	O	Other	No	No	Other	Other	###	1	The	The	DT	DT	_	3	det	_	_
individual	JJ	I-NP	O	Other	No	No	Other	Other	###	2	individual	individual	JJ	JJ	_	3	amod	_	_
values	NNS	I-NP	O	Other	No	No	Other	Other	###	3	values	values	NNS	NNS	_	8	nsubjpass	_	_
for	IN	B-PP	O	Other	No	No	Other	Other	###	4	for	for	IN	IN	_	6	case	_	_
each	DT	B-NP	O	Other	No	No	Other	Other	###	5	each	each	DT	DT	_	6	det	_	_
treatment	NN	I-NP	O	Other	No	No	Other	Other	###	6	treatment	treatment	NN	NN	_	3	nmod	_	_
are	VBP	B-VP	O	Other	No	No	Other	Other	###	7	are	are	VBP	VBP	_	8	auxpass	_	_
presented	VBN	I-VP	O	Other	No	No	Other	Other	###	8	presented	presented	VBN	VBN	_	0	root	_	_
graphically	RB	B-ADVP	O	Other	No	No	Other	Other	###	9	graphically	graphically	RB	RB	_	8	advmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	10	.	.	.	.	_	8	punct	_	_

(	(	O	O	Other	No	No	Other	Other	###	1	(	(	(	(	_	2	punct	_	_
E	NN	B-NP	O	Other	No	No	Other	Other	###	2	E	E	NN	NN	_	4	nmod:npmod	_	_
)	)	O	O	Other	No	No	Other	Other	###	3	)	)	)	)	_	2	punct	_	_
Representative	JJ	B-NP	O	Other	No	No	Other	Other	###	4	Representative	Representative	JJ	JJ	_	6	amod	_	_
Western	JJ	I-NP	O	Other	No	No	Other	Other	###	5	Western	Western	JJ	JJ	_	6	amod	_	_
blot	NN	I-NP	O	Other	No	No	Other	Other	###	6	blot	blot	NN	NN	_	0	root	_	_
showing	VBG	B-VP	O	Other	No	No	Other	Other	###	7	showing	showing	VBG	VBG	_	6	acl	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	8	that	that	IN	IN	_	12	mark	_	_
importin-alpha	NN	B-NP	B-protein	Other	No	No	Other	Other	###	9	importin-alpha	importin-alpha	NN	NN	_	10	compound	_	_
expression	NN	I-NP	O	Other	No	No	Other	Other	###	10	expression	expression	NN	NN	_	12	nsubj	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	11	was	was	VBD	VBD	_	12	aux	_	_
unaffected	JJ	B-ADJP	O	Other	No	No	Other	Other	###	12	unaffected	unaffected	JJ	JJ	_	7	ccomp	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	13	by	by	IN	IN	_	14	case	_	_
inhalation	NN	B-NP	O	Other	No	No	Other	Other	###	14	inhalation	inhalation	NN	NN	_	12	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	15	of	of	IN	IN	_	16	case	_	_
FP	NN	B-NP	O	Other	No	No	Other	Other	###	16	FP	FP	NN	NN	_	14	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	17	.	.	.	.	_	6	punct	_	_

Blot	NNP	B-NP	O	Other	No	No	Other	Other	###	1	Blot	Blot	NNP	NNP	_	3	nsubj	_	_
is	VBZ	B-VP	O	Other	No	No	Other	Other	###	2	is	is	VBZ	VBZ	_	3	cop	_	_
representative	JJ	B-ADJP	O	Other	No	No	Other	Other	###	3	representative	representative	JJ	JJ	_	0	root	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	4	of	of	IN	IN	_	5	case	_	_
gels	NNS	B-NP	O	Other	No	No	Other	Other	###	5	gels	gels	NNS	NNS	_	3	nmod	_	_
from	IN	B-PP	O	Other	No	No	Other	Other	###	6	from	from	IN	IN	_	8	case	_	_
three	CD	B-NP	O	Other	No	No	Other	Other	###	7	three	three	CD	CD	_	8	nummod	_	_
participants	NNS	I-NP	O	Other	No	No	Other	Other	###	8	participants	participants	NNS	NNS	_	5	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	9	.	.	.	.	_	3	punct	_	_

